These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31338640)
1. Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT). Kang D; Kim IR; Park YH; Im YH; Zhao D; Guallar E; Ahn JS; Cho J Support Care Cancer; 2020 Apr; 28(4):1829-1837. PubMed ID: 31338640 [TBL] [Abstract][Full Text] [Related]
2. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study. Kang D; Kim IR; Choi EK; Im YH; Park YH; Ahn JS; Lee JE; Nam SJ; Lee HK; Park JH; Lee DY; Lacouture ME; Guallar E; Cho J Oncologist; 2019 Mar; 24(3):414-420. PubMed ID: 30120165 [TBL] [Abstract][Full Text] [Related]
3. A Botanical Compound for the Treatment of Alopecia Areata and Chemotherapy-Induced Alopecia. Patsner B; Harti S J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S69-S70. PubMed ID: 33099391 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors. Bhoyrul B; Asfour L; Lutz G; Mitchell L; Jerjen R; Sinclair RD; Holmes S; Chaudhry IH; Harries MJ JAMA Dermatol; 2021 Nov; 157(11):1335-1342. PubMed ID: 34586345 [TBL] [Abstract][Full Text] [Related]
5. The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial. You JS; Guo L; Huang M; Shi XL; Lin MD; Guo Z; Cao YL; Sun YZ; Xu Q; Qu WL; Liu HL; Chen JP Trials; 2019 Dec; 20(1):719. PubMed ID: 31831051 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of minoxidil in chemotherapy-induced alopecia. Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968 [TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758 [TBL] [Abstract][Full Text] [Related]
8. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia. Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959 [TBL] [Abstract][Full Text] [Related]
9. The comparison of therapeutic effect of Clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial. Moosavi ZB; Aliabdi M; Golfakhrabadi F; Namjoyan F Arch Dermatol Res; 2020 Apr; 312(3):173-178. PubMed ID: 31707498 [TBL] [Abstract][Full Text] [Related]
10. Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial. Kang D; Cho J; Zhao D; Kim J; Kim N; Kim H; Kim S; Kim JY; Park YH; Im YH; Guallar E; Ahn JS J Clin Oncol; 2024 Sep; 42(26):3115-3122. PubMed ID: 38843479 [TBL] [Abstract][Full Text] [Related]
11. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334 [TBL] [Abstract][Full Text] [Related]
12. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial. Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555 [TBL] [Abstract][Full Text] [Related]
13. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254 [TBL] [Abstract][Full Text] [Related]
14. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres. Chan J; Adderley H; Alameddine M; Armstrong A; Arundell D; Fox R; Harries M; Lim J; Salih Z; Tetlow C; Wong H; Thorp N Eur J Cancer Care (Engl); 2021 May; 30(3):e13395. PubMed ID: 33350015 [TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503 [TBL] [Abstract][Full Text] [Related]